Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Seibel NL, Steinherz PG, Sather HN, Nachman JB, Delaat C, Ettinger LJ, Freyer DR, Mattano LA Jr, Hastings CA, Rubin CM, Bertolone K, Franklin JL, Heerema NA, Mitchell TL, Pyesmany AF, La MK, Edens C, Gaynon PS. Seibel NL, et al. Among authors: steinherz pg. Blood. 2008 Mar 1;111(5):2548-55. doi: 10.1182/blood-2007-02-070342. Epub 2007 Nov 26. Blood. 2008. PMID: 18039957 Free PMC article. Clinical Trial.
Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193P.
Gaynon PS, Bleyer WA, Steinherz PG, Finklestein JZ, Littman PS, Miller DR, Reaman GH, Sather HN, Hammond GD. Gaynon PS, et al. Among authors: steinherz pg. Am J Pediatr Hematol Oncol. 1988 Spring;10(1):42-50. doi: 10.1097/00043426-198821000-00009. Am J Pediatr Hematol Oncol. 1988. PMID: 3056061 Clinical Trial.
Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106.
Gaynon PS, Steinherz PG, Bleyer WA, Ablin AR, Albo VC, Finklestein JZ, Grossman NJ, Novak LJ, Pyesmany AF, Reaman GH, et al. Gaynon PS, et al. Among authors: steinherz pg. J Clin Oncol. 1993 Nov;11(11):2234-42. doi: 10.1200/JCO.1993.11.11.2234. J Clin Oncol. 1993. PMID: 8229139 Clinical Trial.
Young adults 16-21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment.
Nachman J, Sather HN, Buckley JD, Gaynon PS, Steinherz PG, Tubergen DG, Lampkin BC, Hammond GD. Nachman J, et al. Among authors: steinherz pg. Cancer. 1993 May 15;71(10 Suppl):3377-85. doi: 10.1002/1097-0142(19930515)71:10+<3377::aid-cncr2820711741>3.0.co;2-8. Cancer. 1993. PMID: 8490886 Clinical Trial.
Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study.
Uckun FM, Gaynon PS, Sensel MG, Nachman J, Trigg ME, Steinherz PG, Hutchinson R, Bostrom BC, Sather HN, Reaman GH. Uckun FM, et al. Among authors: steinherz pg. J Clin Oncol. 1997 Jun;15(6):2214-21. doi: 10.1200/JCO.1997.15.6.2214. J Clin Oncol. 1997. PMID: 9196133 Clinical Trial.
176 results